The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

Print

[CINP2024] Poster Session

CINP2024 » Poster Session

Schizophrenia 1 - Clinical (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

[P135] Safety and Efficacy of KarXT in Patients with Schizophrenia in the Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials

*Kenneth Kramer1, Stephen K Brannan1, Colin Sauder 1, Inder Kaul1 (1. Karuna Therapeutics )

Keywords:KarXT, Muscarinic receptors , Schizophrenia , xanomeline

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password